Climate change, air pollution and other environmental challenges have a demonstrable impact on public health around the world. As part of the global health and care system, the innovative biopharmaceutical industry has a responsibility to minimise our impact on the planet as well as to research and develop new health products that manage and mitigate health risks from environmental challenges.
Pharmaceutical & Biopharmaceutical companies are already working on initiatives to reduce carbon emissions across their own operations and value chains, invest in renewable electricity and energy efficiency measures, recycle, and cut water use and on bespoke projects which will impact positively on the environment.
Pharma Nature Positive is a platform for all stakeholders in this industry to influence decision making by regulators, governments, investors and other service providers to achieve Nature Net Positive Results. This journal will enable pharma the ability to choose the right services to attain this goal.
